Europe’s Stem Cell Banking market is the second-largest in the world. The presence of activities carried out by the European Union and various organisations will raise the necessity for cord blood banking. Furthermore, uniform regulations implemented by the European government regarding the support of voluntary and free donations, procedures to standardise the testing of donated tissues and cells, and procedures to ensure document safety and traceability would support the growth of the regional market during the study period. Furthermore, the German market had the biggest market share, while the UK market was the European region’s fastest-growing market.
From 2023 to 2032, the Asia-Pacific Market is predicted to develop at the quickest CAGR. the presence of pharmaceutical companies who prioritise Asia’s enormous and mostly untapped population. High investments in the biotechnology industry and cheap clinical trial costs are expected to promote market development in this area. Furthermore, China’s market had the greatest market share, while India’s market was the Asia-Pacific region’s fastest-growing market.
Research Methodology:
After secondary research provided a fundamental understanding of the worldwide Stem Cell Banking Market scenario, extensive primary research was carried out. A number of primary interviews were carried out with industry experts from the supply and demand sides, including C- and D-level executives, product managers, and marketing and sales managers of major manufacturers, distributors, and channel partners from tier 1 and tier 2 companies offering Market, as well as personnel from academia, research, and CROs. These interviews were conducted across five major regions: North America, Europe, Asia Pacific, and the Rest of the World (Latin America & the Middle East & Africa). Participants from the supply-side and demand-side participated in about 70% and 30% of the primary interviews, respectively. Through the use of questionnaires, emails, online surveys, in-person interviews, and phone interviews, this main data was gathered.
The segmentation coverage of the study is provided below.
Stem Cell Banking Market based on Cell type:
- Umbilical Cord Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
Stem Cell Banking Market based on Bank type:
- Private Banks
- Public Banks
- Hybrid Banks
Stem Cell Banking Market based on Application:
- Thalassemia
- Cerebral Palsy
- Diabetes
- Leukemia
- Autism
Stem Cell Banking Market based on Geography:
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific (RoAPAC)
- Latin America (LATAM)
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa (MEA)
- UAE
- Turkey
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
The storage segment led the stem cell banking market by service type in 2020, and this trend is likely to continue during the forecast period, owing to a growth in the number of stem cell banks. However, the processing segment is predicted to develop significantly throughout the forecast period, owing to an increase in R&D efforts in the pharmaceutical industry and advancements in stem cell processing technologies.
The utilised category led the stem cell banking market in 2020, and this trend is likely to continue during the forecast period, owing to a rise in clinical studies for stem cell applications.
The umbilical cord stem cell segment led the market in 2020, and this trend is likely to continue during the forecast period, owing to the increased use of stem cells to treat a variety of medical diseases. The umbilical cord stem cells are easily obtained and pose no harm to the mother or child. However, due to an increase in the number of adult stem cell transplants, the adult stem cell sector is likely to rise significantly throughout the projection period.
Because of the cheap cost of stem cells at public banks, the public sector led the stem cell banking market in 2020, and this trend is likely to continue over the forecast period. However, the private segment is predicted to grow significantly throughout the forecast period, owing to an increase in the number of private stem cell banks and organisations’ initiatives to build biotechnology companies.
The key players operating in the global stem cell banking market are American CryoStem Corporation, Americord Registry LLC, Cordlife Group Limited, Cordlife Group Limited, Cryoholdco De LatinoAmerica, S.A.P.I. DE C.V., StemCyte Cord Blood Bank, Covis Pharma., Global Cord Blood Corporation., Smart cells.and CSG BIO.
- This report illustrates the most vital attributes of the Market, which are driving and providing opportunities.
- This research gives an in-depth analysis of the Market growth on the basis of several segments in the market.
- This report presents the predictions of the past and present trends of the Market.
- This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Stem Cell Banking Market.
List of Tables
TABLE 1. STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 2. STEM CELL BANKING MARKET VALUE FOR UMBILICAL CORD STEM CELLS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. STEM CELL BANKING MARKET VALUE FOR ADULT STEM CELLS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. STEM CELL BANKING MARKET VALUE FOR EMBRYONIC STEM CELLS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 6. STEM CELL BANKING MARKET VALUE FOR PRIVATE BANKS, 2021-2030 (USD BILLION)
TABLE 7. STEM CELL BANKING MARKET VALUE FOR PUBLIC BANKS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 8. STEM CELL BANKING MARKET VALUE FOR HYBRID BANKS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 9. STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 10. STEM CELL BANKING MARKET VALUE FOR THALASSEMIA, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 11. STEM CELL BANKING MARKET VALUE FOR CEREBRAL PALSY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 12. STEM CELL BANKING MARKET VALUE FOR DIABETES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 13. STEM CELL BANKING MARKET VALUE FOR LEUKEMIA, 2021-2030 (USD BILLION)
TABLE 14. STEM CELL BANKING MARKET VALUE FOR AUTISM, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 15. NORTH AMERICA STEM CELL BANKING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 16. NORTH AMERICA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 17. NORTH AMERICA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 18. NORTH AMERICA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 19. U.S STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 20. U.S STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 21. U.S STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 22. CANADA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 23. CANADA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 24. CANADA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 25. MEXICO STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 26. MEXICO STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 27. MEXICO STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 28. EUROPE STEM CELL BANKING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 29. EUROPE STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 30. EUROPE STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 31. EUROPE STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 32. GERMANY STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 33. GERMANY STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 34. GERMANY STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 35. U.K STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 36. U.K STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 37. U.K STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 38. FRANCE STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 39. FRANCE STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 40. FRANCE STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 41. ITALY STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 42. ITALY STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 43. ITALY STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 44. SPAIN STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 45. SPAIN STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 46. SPAIN STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 47. ROE STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 48. ROE STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 49. ROE STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 50. ASIA PACIFIC STEM CELL BANKING MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 51. ASIA PACIFIC STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 52. ASIA PACIFIC STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 53. ASIA PACIFIC STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 54. CHINA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 55. CHINA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 56. CHINA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 57. INDIA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 58. INDIA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 59. INDIA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 60. JAPAN STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 61. JAPAN STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 62. JAPAN STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 63. REST OF APAC STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 64. REST OF APAC STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 65. REST OF APAC STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 66. LATIN AMERICA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 67. LATIN AMERICA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 68. LATIN AMERICA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 69. BRAZIL STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 70. BRAZIL STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 71. BRAZIL STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 72. ARGENTINA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 73. ARGENTINA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 74. ARGENTINA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 75. MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 76. MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 77. MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 78. SAUDI ARABIA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 79. SAUDI ARABIA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 80. SAUDI ARABIA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 81. UAE STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 82. UAE STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 83. UAE STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 84. REST OF MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY CELL TYPE, 2021-2030 (USD BILLION)
TABLE 85. REST OF MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY BANK TYPE, 2021-2030 (USD BILLION)
TABLE 86. REST OF MIDDLE EAST AND AFRICA STEM CELL BANKING MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 87. TRINA SOLAR (CHINA) : FINANCIALS
TABLE 88. TRINA SOLAR (CHINA) : PRODUCTS & SERVICES
TABLE 89. TRINA SOLAR (CHINA) : RECENT DEVELOPMENTS
TABLE 90. FIRST SOLAR (U.S.): FINANCIALS
TABLE 91. FIRST SOLAR (U.S.): PRODUCTS & SERVICES
TABLE 92. FIRST SOLAR (U.S.): RECENT DEVELOPMENTS
TABLE 93. YINGLI SOLAR (CHINA): FINANCIALS
TABLE 94. YINGLI SOLAR (CHINA): PRODUCTS & SERVICES
TABLE 95. YINGLI SOLAR (CHINA): RECENT DEVELOPMENTS
TABLE 96. TATA POWER SOLAR SYSTEM LTD (INDIA): FINANCIALS
TABLE 97. TATA POWER SOLAR SYSTEM LTD (INDIA): PRODUCTS & SERVICES
TABLE 98. TATA POWER SOLAR SYSTEM LTD (INDIA): RECENT DEVELOPMENTS
TABLE 99. ABENGOA (SPAIN): FINANCIALS
TABLE 100. ABENGOA (SPAIN): PRODUCTS & SERVICES
TABLE 101. ABENGOA (SPAIN): RECENT DEVELOPMENTS
TABLE 102. CANADIAN SOLAR INC. (CANADA): FINANCIALS
TABLE 103. CANADIAN SOLAR INC. (CANADA): PRODUCTS & SERVICES
TABLE 104. CANADIAN SOLAR INC. (CANADA): RECENT DEVELOPMENTS
TABLE 105. WAAREE GROUP (INDIA): FINANCIALS
TABLE 106. WAAREE GROUP (INDIA): PRODUCTS & SERVICES
TABLE 107. WAAREE GROUP (INDIA): DEVELOPMENTS
TABLE 108. GENERAL ELECTRIC COMPANY (U.S.): FINANCIALS
TABLE 109. GENERAL ELECTRIC COMPANY (U.S.): PRODUCTS & SERVICES
TABLE 110. GENERAL ELECTRIC COMPANY (U.S.): RECENT DEVELOPMENTS
TABLE 111. SUNPOWER CORPORATION (U.S.): FINANCIALS
TABLE 112. SUNPOWER CORPORATION (U.S.): PRODUCTS & SERVICES
TABLE 113. SUNPOWER CORPORATION (U.S.): RECENT DEVELOPMENTS
TABLE 114. URJA GLOBAL LIMITED (INDIA): FINANCIALS
TABLE 115. URJA GLOBAL LIMITED (INDIA): PRODUCTS & SERVICES
TABLE 116. URJA GLOBAL LIMITED (INDIA): RECENT DEVELOPMENTS
